Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults-Reference-Cited by-同舟云学术

Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults

Published:2019-08-14 Issue:2 Volume:9 Page:203-213
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Van Hecken Anne¹,Burckhardt Björn B.²,Khalil Feras²,Hoon Jan¹,Klingmann Ingrid³,Herbots Marissa¹,Laeer Stephanie²,Lagler Florian B.⁴,Breitkreutz Jörg⁵

Affiliation:

1. Center for Clinical PharmacologyUniversity Hospitals of Leuven Leuven Belgium

2. Institute of Clinical Pharmacy and PharmacotherapyHeinrich Heine University Düsseldorf Germany

3. Pharmaplex bvba Wezembeek‐Oppem Belgium

4. Paracelsus Medical University Salzburg Austria

5. Ethicare GmbH Haltern am See Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.728

Reference29 articles.

1. 10 years EU regulation of pediatric medicines – impact on cardiovascular drug formulations

2. A Double-Blind, Placebo-Controlled, Dose-Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension

3. Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review

4. Enalapril for severe heart failure in infancy.

5. Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies);Pharmaceutics;2022-05-30

2. From paediatric formulations development to access: Advances made and remaining challenges;British Journal of Clinical Pharmacology;2022-05-18

3. Optimization of treatment and prevention of metabolic and functional disorders in diabetic nephropathy;Profilakticheskaya meditsina;2022

4. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets;European Journal of Pharmaceutics and Biopharmaceutics;2021-11

5. Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press;International Journal of Pharmaceutics;2021-06